Trademark Search in Canada

RISURJJA

View On IC.GC.CA

ADVERTISED

on 2 Apr 2025

Last Applicant/ Owned by

GlaxoSmithKline LLC

Corporation Service Company251 Little Falls DriveWilmington, DE 19808

Serial Number

2077957 filed on 15^th Jan 2021

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

H3B1R1

RISURJJA

Trademark usage description

pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, Read More

Classification Information

Class [005]
Pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification kind code

Mark Details

Serial Number

2077957

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 23^rd Sept 2024	Search Recorded
Submitted for opposition 80 on 20^th Mar 2023	Change of Title Registered
Submitted for opposition 135 on 16^th Feb 2023	Amendment to Application
Submitted for opposition 135 on 8^th Feb 2023	Amendment to Application
Submitted for opposition 83 on 1^st Feb 2023	Assignment Correspondence Created
Submitted for opposition 48 on 12^th Oct 2022	Agent Changed
Submitted for opposition 287 on 27^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 15^th Jan 2021	Filed
Submitted for opposition 1 on 15^th Jan 2021	Created
Submitted for opposition 31 on 15^th Jan 2021	Formalized